KELSEY ROSEN: Open Payments
NPI 1568831758 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 18 payments from 11 companies in 2025. Trend: 2023 $346 · 2024 $362 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Baxter Healthcare | 6 | $186 |
| Organogenesis Inc. | 3 | $59 |
| Kerecis Limited | 1 | $49 |
| INTUITIVE SURGICAL, INC. | 1 | $34 |
| W. L. Gore & Associates, Inc. | 1 | $30 |
| Reprise Biomedical, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Smith+Nephew, Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Solventum Corporation | 1 | $19 |
Products named: TISSEEL, Kerecis SurgiClose, CYGNUS DUAL, Da Vinci Surgical System, GORE SYNECOR Biomaterial, Miro3D, TEFLARO, COLLAGENASE SANTYL.
Industry payments across MD — which companies pay providers there.
